METABOLIC SOLUTIONS DEVELOPMENT CO

Basic Information

161 E. Michigan Ave, 4th Floor
KALAMAZOO, MI, 49007-3926

Company Profile

n/a

Additional Details

Field Value
DUNS: 801994281
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease

    Amount: $121,956.00

    ? DESCRIPTION (provided by applicant): Polycystic kidney disease (PKD) is a term applied to a group of inherited disorders characterized by the presence of cysts in the kidney although multiple or ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

    Amount: $1,136,022.00

    DESCRIPTION (provided by applicant): Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the United States. This condition encompasses both hepatic steatosis and the more ...

    STTR Phase II 2011 Department of Health and Human Services
  3. PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes

    Amount: $1,242,620.00

    DESCRIPTION (provided by applicant): The overall objective of our proposed research is to discover a PPARg-free thiazolidinedione (TZD) which shows antidiabetic activity in a rodent model of Type 2 di ...

    STTR Phase II 2010 Department of Health and Human Services
  4. PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes

    Amount: $139,864.00

    DESCRIPTION (provided by applicant): The overall objective of our proposed research is to discover a PPARg-free thiazolidinedione (TZD) which shows antidiabetic activity in a rodent model of Type 2 di ...

    STTR Phase I 2009 Department of Health and Human Services
  5. Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

    Amount: $140,911.00

    DESCRIPTION (provided by applicant): The overall objective of the proposed research is to discover a PPAR?-sparing thiazolidinedione (TZD) which displays efficacy in a rodent model of non-alcoholic fa ...

    STTR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government